Studies have demonstrated that S100 A4, a member of the S100 calcium-binding protein family, suppresses p53 activity by modulating its post-translational modifications (e.g., phosphorylation and acetylation), thereby promoting pancreatic cancer cell proliferation, migration, and disease progression41. This evidence concerns the gene TP53 and familial pancreatic carcinoma.